Reactome | Active ALK phosphorylates IRS1

Active ALK phosphorylates IRS1

Stable Identifier

R-HSA-9700168

Type

Reaction [transition]

Species

Homo sapiens

Compartment

plasma membrane, cytosol

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

IRS1 is phosphorylated downstream of active ALK in a manner that is dependent on ALK kinase activity. Based on studies in NPM-ALK fusions, ALK likely phosphorylates IRS1 on one or more tyrosine residues, but the target amino acid(s) have not been identified directly in the context of the full-length ALK receptor (Fujimoto et al 1996; Stoica et al, 2001; Motegi et al, 2004; reviewed in Roskoski, 2013; Delle Corte et al, 2018). ALK-dependent IRS1 phosphorylation activates the MAP kinase signaling pathway and promotes cellular proliferation, but direct binding of a RAS GEF such as GRB2:SOS1 has not been shown (reviewed in Turner and Alexander, 2006; Chiarle et al, 2008; Roskoski, 2013).

Literature References

PubMed ID	Title	Journal	Year
15226403	ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth Motegi, A, Fujimoto, J, Kotani, M, Sakuraba, H, Yamamoto, T	J. Cell. Sci.	2004
29455642	Role and targeting of anaplastic lymphoma kinase in cancer Della Corte, CM, Viscardi, G, Di Liello, R, Fasano, M, Martinelli, E, Troiani, T, Ciardiello, F, Morgillo, F	Mol. Cancer	2018
18097461	The anaplastic lymphoma kinase in the pathogenesis of cancer Chiarle, R, Voena, C, Ambrogio, C, Piva, R, Inghirami, G	Nat. Rev. Cancer	2008
16482213	Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells Turner, SD, Alexander, DR	Leukemia	2006
8633037	Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5) Fujimoto, J, Shiota, M, Iwahara, T, Seki, N, Satoh, H, Mori, S, Yamamoto, T	Proc. Natl. Acad. Sci. U.S.A.	1996
23201355	Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition Roskoski, R	Pharmacol. Res.	2013
11278720	Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin Stoica, GE, Kuo, AH, Aigner, A, Sunitha, I, Souttou, B, Malerczyk, C, Caughey, DJ, Wen, D, Karavanov, A, Riegel, AT, Wellstein, A	J Biol Chem	2001